Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    " May 15, 2013":" June 14, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Towards HIV Functional Cure
Condition: Chronic HIV-1 Infection
Intervention: Other: Antiretroviral treatment interruption
22 Completed
Has Results
Study of A Combination Pill With GS-7977 and GS-5885 for Hepatitis C in People With HIV
Conditions: Hepatitis C;   HIV
Intervention: Drug: GS-7977/GS- 5885 FDC
23 Completed HSV Oral Reactivation in Children
Conditions: HSV-1;   HIV
Intervention: Other: Underlying medical illness
24 Recruiting Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone
Conditions: Opiate Dependence;   Human Immunodeficiency Virus
Interventions: Drug: injectable naltrexone;   Drug: placebo comparator
25 Recruiting Tauroursodeoxycholic Acid for Protease-inhibitor Associated Insulin Resistance
Conditions: HIV Related Insulin Resistance;   Protease Inhibitor Related Insulin Resistance;   Endoplasmic Reticulum Stress
Interventions: Drug: Tauroursodeoxycholic acid;   Other: Placebo tablet
26 Active, not recruiting Thai MSM/TG Test and Treat Study
Conditions: HIV Testing Rate;   Acceptance of Immediate ART
Intervention:
27 Active, not recruiting Multicomponent Intervention to Reduce Sexual Risk and Substance Use
Conditions: HIV;   Sexually Transmitted Infections;   Substance Use
Intervention: Behavioral: MI + CBST Intervention
28 Active, not recruiting Quantification of Immune Cells in Women Using Contraception (CHIC II)
Conditions: HIV;   Immune Cells (Mucosal and Systemic);   Contraception
Interventions: Drug: levonorgestrel exposure;   Drug: DMPA exposure;   Drug: etonogestrel exposure;   Device: IUD insertion;   Device: subdermal contraceptive implant insertion
29 Completed A Phase I/IIa Safety & Immunogenicity of AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456)
Conditions: Latent Tuberculosis Bacteriology and Histology Unknown;   Latent Tuberculosis
Interventions: Biological: AERAS-456;   Biological: Placebo
30 Enrolling by invitation Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants
Condition: Tuberculosis
Interventions: Biological: AERAS-404;   Biological: Placebo
31 Completed Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia
Conditions: Opiate Dependence;   Stimulant Dependence
Intervention: Drug: Atomoxetine
32 Unknown  Trial of Methadone Maintenance Versus Methadone Detox in Jail
Condition: Opioid-Related Disorders
Interventions: Behavioral: Methadone Maintenance;   Behavioral: Linkage to methadone maintenance
33 Recruiting Thinking and Memory Problems in People With HIV
Conditions: Acquired Immunodeficiency;   Neurocognitive Disorders
Intervention:
34 Completed HIV/STI Risk Reduction for Incarcerated Women With Interpersonal Violence
Conditions: Unsafe Sex;   Physical Violence;   Sexual Assault;   Sexual Abuse
Interventions: Behavioral: Nutrition Program (NP);   Behavioral: Women's Prison CoOp (WPC)
35 Recruiting Intensive Models of HCV Care for Injection Drug Users
Conditions: Hepatitis C;   Medication Adherence
Intervention: Other: Intensive Models (mDOT and CGT) of HCV Care
36 Completed Probiotics in the Management of Necrotizing Enterocolitis in HIV-exposed Premature Infants
Condition: Necrotizing Enterocolitis
Interventions: Dietary Supplement: Probiotic;   Dietary Supplement: Placebo
37 Completed Optimizing Kidney Transplant Informed Consent
Condition: End-stage Kidney Disease
Intervention: Behavioral: Inform Me: web-based education tool

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Study has passed its completion date and status has not been verified in more than two years.